HR job title
- Clinical Professor
- Contact Info
- ORCiD
- 0000-0001-5797-7849
Udeani, George Clinical Professor and Department Head of Pharmacy Practice
Positions
- Clinical Professor and Department Head of Pharmacy Practice, Pharmacy Practice, Irma Lerma Rangel School of Pharmacy
- Overview
- Publications
- Research
- Teaching
- Background
- Contact
- Other
- View All
Overview
Publications
selected publications
-
academic article
-
Rogers, S., Silva, P. J., Udeani, G., Deleon, M., Mutyala, S., Panahi, L., ... Ramos, K. S.
(2024).
Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation. Drugs in R and D.
-
Fontana, S., Panahi, L., Udeani, G., Surani, S., & Desai, D.
(2022).
Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana. Cureus.
14(8), e27866.
-
Arredondo, E., DeLeon, M., Masozera, I., Panahi, L., Udeani, G., Tran, N., ... Shiver, T. L.
(2022).
Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea. Medicina.
58(2), 225-225.
-
Ngo, H., Mbadugha, U. J., Cepeda, F., Surani, S., & Udeani, G.
(2022).
Clinical and Economic Impact of Rapid Blood Pathogen Identification Via Verigene. Cureus.
14(10), e30366.
-
Panahi, L., Udeani, G., Ho, S., Knox, B., & Maille, J.
(2021).
Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management. Medicina.
57(11), 1173-1173.
-
Arredondo, E., Udeani, G., Panahi, L., Taweesedt, P. T., & Surani, S.
(2021).
Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know. Cureus.
13(9), e17843.
-
Panahi, L., Surani, S. S., Udeani, G., Patel, N. P., & Sellers, J.
(2021).
Hepatotoxicity Secondary to Levofloxacin Use. Cureus.
13(6), e15973.
-
Silva, P., Jacobs, D., Kriak, J., Abu-Baker, A., Udeani, G., Neal, G., & Ramos, K.
(2021).
Implementation of Pharmacogenomics and Artificial Intelligence Tools for Chronic Disease Management in Primary Care Setting. Journal of Personalized Medicine.
11(6), 443-443.
-
Panahi, L., Udeani, G., Horseman, M., Weston, J., Samuel, N., Joseph, M., Mora, A., & Bazan, D.
(2021).
Review of Medical Therapies for the Management of Pulmonary Embolism. Medicina.
57(2), 110-110.
-
Kumar, N., Surani, S., Udeani, G., Mathew, S., John, S., Sajan, S., & Mishra, J.
(2021).
Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. LIFE SCIENCES.
278, 119544-119544.
-
Arredondo, E., Udeani, G., Horseman, M., Hintze, T. D., & Surani, S.
(2021).
Role of Clinical Pharmacists in Intensive Care Units. Cureus.
13(9), e17929.
-
Mbadugha, U. J., Surani, S., Akuffo, N., & Udeani, G.
(2021).
Antimicrobial Therapy for Pneumonia or Fluid Overload?. Cureus.
13(1), e12719.
-
Patel, P. H., Nguyen, M., Rodriguez, R., Surani, S., & Udeani, G.
(2021).
Omecamtiv Mecarbil: A Novel Mechanistic and Therapeutic Approach to Chronic Heart Failure Management. Cureus.
13(1), e12419.
-
Panahi, L., Saenz Ii, J. A., Nguyen, N., Udeani, G., & Surani, S.
(2020).
Hypercoagulation from Concomitant Administration of Tamoxifen and Warfarin. Cureus.
12(5), e8114.
-
Kalani, C., Venigalla, T., Bailey, J., Udeani, G., & Surani, S.
(2020).
Sepsis Patients in Critical Care Units with Obesity: Is Obesity Protective?. Cureus.
12(2), e6929.
-
Kalani, C., Awudi, E., Alexander, T., Udeani, G., & Surani, S.
(2020).
132: EFFICACY OF DOACS FOR VTE TREATMENT IN COMPARISON TO WARFARIN IN MORBIDLY OBESE PATIENTS. Critical Care Medicine.
48(1), 49-49.
-
Kalani, C., Awudi, E., Alexander, T., Udeani, G., & Surani, S.
(2019).
Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients. Hospital practice (1995).
47(4), 181-185.
-
Deol, H. S., Surani, S. R., & Udeani, G.
(2019).
Inter-rater Reliability of the Ramsay Sedation Scale for Critically-ill Intubated Patients. Cureus.
11(10), e6021.
-
Udeani, G., Surani, S., & Akuffo, N.
(2019).
USE OF A CLINICAL DECISION SUPPORT SYSTEM TO MONITOR AND MANAGE PATIENTS AT HIGH RISK FOR CLOSTRIDIUM DIFFICILE INFECTIONS. Chest.
156(4), a1616-A1616.
-
Johnson, N., Varughese, B., De La Torre, M. A., Surani, S. R., & Udeani, G.
(2019).
A Review of Respiratory Biologic Agents in Severe Asthma. Cureus.
11(9), e5690.
-
Udeani, G., Oke, C., Uche, M., & Surani, S.
(2019).
INCIDENCE OF NEGATIVE URINE CULTURES AND ANTIBIOTIC USE WITH A URINALYSIS CULTURE SCREEN AND REFLEX ALGORITHM. Chest.
155(4), 248a-248A.
-
Udeani, G., Oke, C., Mbadugha, U., Surani, S., & Gonzalez, G.
(2019).
PHARMACOECONOMIC IMPACT OF URINALYSIS CULTURE SCREEN AND REFLEX ALGORITHM ON ANTIMICROBIAL THERAPY. Chest.
155(4), 250a-250A.
-
KALANI, C., HENRY, E. A., ALEXANDER, T., UDEANI, G., & SURANI, S.
(2018).
EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN MORBIDLY OBESE PATIENTS. Chest.
154(4), 108a-108A.
-
BAILEY, J., WILSON, M., AKUFFO, N., UDEANI, G., & MBADUGHA, U.
(2018).
EVALUATION OF SUGAMMADEX VS NEOSTIGMINE IN THE REVERSAL OF NEUROMUSCULAR BLOCKADE. Chest.
154(4), 890a-890A.
-
UDEANI, G., NGO, H., MBADUGHA, U., CEPEDA, F., & SURANI, S.
(2018).
VERIGENE GRAM-POSITIVE BLOOD CULTURE TESTING: CLINICAL AND PHARMACOECONOMIC IMPACT. Chest.
154(4), 835a-835A.
-
Mbadugha, U., Bullen, M., Akuffo, N., & Udeani, G.
(2017).
Antimicrobial Therapy for Pneumonia: Role of Brain Natriuretic Peptide and Left Ventricular Ejection Fraction. Chest.
152(4), a125-A125.
-
Nowak, M., Hayes, J. M., Jiang, A., Kaye, K. S., & Udeani, G.
(2017).
Ceftaroline Fosamil for the Treatment of Intensive Care Unit Patients With Pneumonia: CAPTURE Study Experience. Open Forum Infectious Diseases.
4(suppl_1), s582-s583.
-
Deol, H., Dimtri, F., Minaie, A., Surani, S., & Udeani, G.
(2017).
Role of Ramsay Sedation Scale in Sedative Dosage Modulation for Critically-Ill Intubated Patients. Chest.
152(4), a330-A330.
-
Mbadugha, U., Bullen, M., Akuffo, N., & Udeani, G.
(2017).
P225 Evaluation of antimicrobial therapy in the ICU - fluid overload or pneumonia?. Chest.
151(5), a124-A124.
-
Donald, B. J., Surani, S., Deol, H. S., Mbadugha, U. J., & Udeani, G.
(2017).
Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy. 11, 3559-3566.
-
Udeani, G., Pasquale, T., Kaye, K., & Jandourek, A.
(2016).
675. Critical Care Medicine.
44(12), 245-245.
-
Kaye, K., Ramani, A., Udeani, G., Pasquale, T., & Friedland, H. D.
(2016).
Clinical Use of Ceftaroline Fosamil for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Open Forum Infectious Diseases.
3(suppl_1), 1263.
-
Narang, R., Narang, D., Narang, S., & Udeani, G.
(2016).
Management of Bronchopleural Fistula With the Nutritional Supplement-Juven, Vitamins A, and C, Zinc Gluconate, and Folic Acid. Chest.
150(4), 567a-567A.
-
Udeani, G., Akuffo, N., Evans, J., Surani, S., & High, J.
(2016).
Real Time Applied Therapeutics in the Critical Care Environment: Role of a Data Mining Clinical Decision Support Tool. Chest.
150(4), 226a-226A.
-
Udeani, G., Akuffo, N., Evans, J., Surani, S., & High, J.
(2016).
Use of a Data Mining Clinical Decision Support Tool to Optimize Pharmaceutical Care. Chest.
149(4), a237-A237.
-
Udeani, G., Guervil, D., Johnson, L. B., & Kaye, K.
(2015).
Ceftaroline Fosamil for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: CAPTURE Study Experience. Open Forum Infectious Diseases.
2(suppl_1), 1817.
-
Kaye, K., Udeani, G., Johnson, L. B., & Cannon, C. M.
(2015).
Location of Care and Ceftaroline Fosamil Use for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Community-Acquired Bacterial Pneumonia (CABP): CAPTURE Study Experience. Open Forum Infectious Diseases.
2(suppl_1), 1544.
-
Narang, R., Narang, D., Narang, S., salman, j., Quyen, N., & Udeani, G.
(2015).
Good, Bad, and Ugly on Vaping. Chest.
148(4), 385a-385b.
-
Kaye, K. S., Udeani, G., Cole, P., & Friedland, H. D.
(2015).
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia. 43(3), 144-149.
-
Evans, J. D., Udeani, G., Cole, P., & Friedland, H. D.
(2014).
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients. Postgraduate medicine.
126(5), 128-134.
-
Udeani, G., Evans, J., Cole, P., & Friedland, H. D.
(2014).
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients. Hospital practice (1995).
42(3), 109-115.
-
Ramani, A., Udeani, G., Evans, J., Jandourek, A., Cole, P., Smith, A., & David Friedland, H.
(2014).
Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience. 26(4), 229-234.
-
Udeani, G., & Surani, S.
(2011).
Evaluation of the Use of Peripheral Parenteral Nutrition Therapy at a Community Institution. Chest.
140(4), 281a-281A.
-
Shin, Y. G., Udeani, G. O., Kosmeder, J. W., Zhao, G. M., Dagar, S., Onyuksel, H., ... Pezzuto, J. M.
(2004).
Identification of degradation product of deguelin and its stability using liquid chromatography and electrospray/mass spectrometry. Journal of Liquid Chromatography and Related Technologies.
27(6), 1057-1069.
-
Udeani, G. O., Zhao, G. M., Shin, Y. G., Kosmeder, J. W., Beecher, C. W., Kinghorn, A. D., ... Pezzuto, J. M.
(2001).
Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Cancer Chemotherapy and Pharmacology.
47(3), 263-268.
-
Udeani, G. O., Zhao, G. M., Geun Shin, Y., Cooke, B. P., Graham, J., Beecher, C. W., Kinghorn, A. D., & Pezzuto, J. M.
(1999).
Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. 20(8), 379-383.
-
Udeani, G. O., Gerhauser, C., Thomas, C. F., Moon, R. C., Kosmeder, J. W., Kinghorn, A. D., Moriarty, R. M., & Pezzuto, J. M.
(1997).
Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Research.
57(16), 3424-3428.
-
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., ... Pezzuto, J. M.
(1997).
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science.
275(5297), 218-220.
-
Udeani, G. O., Singh, K., Mullane, M. R., & Lad, T. E.
(1996).
Cisplatin nephrotoxicity in a patient with a single kidney. Annals of Pharmacotherapy.
30(7-8), 782-786.
-
WANG, P. L., UDEANI, G. O., & JOHNSTON, T. P.
(1995).
INHIBITION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ADSORPTION TO POLYVINYL-CHLORIDE USING A NONIONIC SURFACTANT. International Journal of Pharmaceutics.
114(2), 177-184.
-
Udeani, G. O., Bass, J., & Johnston, T. P.
(1994).
Compatibility of oral morphine sulfate solution with enteral feeding products. Annals of Pharmacotherapy.
28(4), 451-455.
-
Mohindra, S. K., & Udeani, G. O.
(1993).
Treatment of massive pulmonary embolism with centrally administered tissue-type plasminogen activator. Annals of Emergency Medicine.
22(8), 1349-1352.
-
Meyer, H., Tromp, T., van der Kleijn, E., Fields, S. M., Moors, J., Enlund, H., ... Bonal, J.
(1993).
Abstracts of papers and posters safe handling of medicines. 15(Suppl 7), g3-g22.
-
Mohindra, S. K., & Udeani, G. O.
(1991).
Intravenous esmolol in acute aortic dissection. DICP : the annals of pharmacotherapy.
25(7-8), 735-738.
-
Mohindra, S. K., Udeani, G. O., & Abrahamson, D.
(1989).
Cardiac tamponade associated with drug-induced systemic lupus erythematosus. Critical Care Medicine.
17(9), 961-962.
-
Mohindra, S. K., & Udeani, G. O.
(1989).
Long-acting verapamil and heart failure. Journal of the American Medical Association (JAMA).
261(7), 994-994.
-
Muoghalu, B. U., Udeani, G. O., & Idemyor, V. T.
(1989).
Naloxone therapy in stroke. Clinical pharmacy.
8(2), 90-90.
-
Rogers, S., Silva, P. J., Udeani, G., Deleon, M., Mutyala, S., Panahi, L., ... Ramos, K. S.
(2024).
Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation. Drugs in R and D.
-
chapter
-
Sadera, C., Halliburton, S., Panahi, L., & Udeani, G.
(2022).
Introductory Chapter: Pulmonary Embolism. New Knowledge about Pulmonary Thromoboembolism.
IntechOpen.
-
Panahi, L., Udeani, G., Scott Tenpas, A., Ofili, T., Marie Aguilar, E., Burchard, S., ... Vara, N.
(2022).
Pharmacological Management of Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
IntechOpen.
-
Panahi, L., Udeani, G., Horseman, M., Weston, J., Samuel, N., Joseph, M., ... Patel, P.
(2021).
Anticoagulants in the Management of Pulmonary Embolism. George Udeani. (Eds.),
New Knowledge about Pulmonary Thromoboembolism.
(pp. Ch.-2).
IntechOpen.
-
Bailey, J., Udeani, G., & Surani, S.
(2018).
BTreatment review of hospital acquired infections. Fighting Antimicrobial Resistance.
(pp. 93-114).
International Association of Physical Chemists (IAPC).
-
Pezzuto, J. M., Beecher, C., Fong, H., Farnsworth, N. R., Mehta, R. G., Moon, R. C., ... Kinghorn, A. D.
(1998).
Discovery and Characterization of Natural Product Cancer Chemopreventive Agents. Rahman, A. U., & Iqbal, M. (Eds.),
New Trends in Natural Product.
(pp. 95-107).
CRC Press.
-
Wilks, A., Panahi, L., Udeani, G., & Surani, S.
Review of Gastroesophageal Reflux Pharmacotherapy Management. Gastroesophageal Reflux Disease - A Growing Concern.
IntechOpen.
-
Sadera, C., Halliburton, S., Panahi, L., & Udeani, G.
(2022).
Introductory Chapter: Pulmonary Embolism. New Knowledge about Pulmonary Thromoboembolism.
IntechOpen.
-
conference paper
-
Aiyer, I., Surani, S., Ratnani, I., Ramirez, M., Udeani, G., Varon, J., & Khan, A.
(2019).
PREVALENCE OF USE OF LAMA LABA REGIMEN USE FOR MANAGEMENT OF COPD IN REAL WORLD PRIMARY CARE SETTING. Chest.
218A-218A.
-
Donald, B., Udeani, G., Surani, S., Azali, L., & Patel, H.
(2017).
Concurrent validity of sequential organ failure assessment versus systemic inflammatory response syndrome score for patients in the intensive care unit. Chest.
142A-142A.
-
Deol, H., Minaie, A., Surani, S., & Udeani, G.
(2017).
Reliability and utility of the Ramsay sedation scale for dosing sedatives in critically ill intubated patients. Chest.
143A-143A.
-
Udeani, G., & Surani, S.
(2014).
Antibiotic Stewardship in Small Community Hospital. Chest.
146a-1-146a-2-146A.
-
Kinghorn, A. D., Farnsworth, N. R., Soejarto, D. D., Cordell, G. A., Pezzuto, J. M., Udeani, G. O., ... Shu, Y. Z.
(1999).
Novel strategies for the discovery of plant-derived anticancer agents. Pure and Applied Chemistry.
1611-1618.
-
Aiyer, I., Surani, S., Ratnani, I., Ramirez, M., Udeani, G., Varon, J., & Khan, A.
(2019).
PREVALENCE OF USE OF LAMA LABA REGIMEN USE FOR MANAGEMENT OF COPD IN REAL WORLD PRIMARY CARE SETTING. Chest.
218A-218A.
-
review
-
Horseman, M., Panahi, L., Udeani, G., Tenpas, A. S., Verduzco, R., Patel, P. H., ... Surani, S.
(2022).
Drug-Induced Hyperthermia Review. Cureus.
e27278.
-
Horseman, M., Panahi, L., Udeani, G., Tenpas, A. S., Verduzco, R., Patel, P. H., ... Surani, S.
(2022).
Drug-Induced Hyperthermia Review. Cureus.
e27278.
Research
principal investigator on
- A multicenter, observational, retrospective, registry study to evaluate the use of ceftaroline fosamil (TeflaroTM) in the treatment of patients with complicated skin and skin structure infection or community-acquired bacterial pneumonia. awarded by Allergan - (Irvine, California, United States) 2012 - 2017
- Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program. awarded by JMI Laboratories - (North Liberty, Iowa, United States) 2012 - 2014
- Stability and pharmacokinetics of morphine sulfate/enteral feeding awarded by Hikma Pharmaceuticals (Germany) - (Planegg, Germany) 1992 - 1997
- Evaluation of ketorolac in sickle cell painful episodes awarded by Roche - (Nutley, New Jersey, United States) 1991 - 1993
- In vitro susceptibility of ampicillin/sulbactam and ticarcillin/clavulanate awarded by GlaxoSmithKline - (Philadelphia, Pennsylvania, United States) 1988 - 1989
- Impact of rapid susceptibility testing and pharmacy interventions on antimicrobic utilization, patient care and cost reduction awarded by Abbott - (Chicago, Illinois, United States) 1987 - 1988
- A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI). awarded by Summit - (Abingdon, United Kingdom) 2020 -
co-principal investigator on
- A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects with Staphylococcus aureus Bacteremia or with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia awarded by Allergan - (Irvine, California, United States) 2012 - 2014
- Novel strategies for plant-derived anticancer agents (U01/U19 CA 52956) awarded by National Institutes of Health - (Bethesda, Maryland, United States) 1998 - 2000
- Natural inhibitors of carcinogenesis (PO1 CA48112) awarded by National Institutes of Health - (Bethesda, Maryland, United States) 1994 - 1998
- High school student research opportunities program grant awarded by National Institutes of Health - (Bethesda, Maryland, United States) 1995 - 1996
- A double-blind, randomized trial of cefepime versus ceftazidime for the empiric treatment of febrile episodes in neutropenic cancer patients awarded by Bristol-Myers Squibb - (New York, New York, United States) 1993 - 1995
- Multi-center study to determine the safety and efficacy of sustained versus immediate release codeine sulfate on chronic cancer pain (CSR 0192) awarded by Hikma Pharmaceuticals (Germany) - (Planegg, Germany) 1992 - 1994
- Multi-center study to determine the safety and efficacy of sustained versus immediate release codeine sulfate on chronic cancer pain (CSR 0292) awarded by Hikma Pharmaceuticals (Germany) - (Planegg, Germany) 1992 - 1994
- A multicenter, randomized, double-blind, placebo-controlled pilot study of the safety and efficacy of Rheothrx (Poloxamer 188) injection in patients with sickle cell disease in acute vaso-occlusive crisis awarded by Burroughs Wellcome Fund - (Durham, North Carolina, United States) 1992 - 1993
- Reducing healthcare workers absenteeism in SARS-CoV-2 Pandemic by Enhanced trained immune responses through Bacillus Calmette-Guerin vaccination, a randomized trial awarded by Texas A&M University - (College Station, Texas, United States) 2020 -
Teaching
teaching activities
- PHAR777 Sterile Products/iv Admixtures Instructor
- PHAR785 Independent Study Instructor
- PHAR813 Ipt Viii: Onc, Trnsplt, Genomc Instructor
Background
education and training
- National Institutes of Health - (Bethesda, Maryland, United States) , Postdoctoral Training
- D.Sc. in Cancer Research, Warnborough College - (Canterbury, United Kingdom) 2006
- B.S. in Pharmacy, University of Minnesota - (Minneapolis, Minnesota, United States) 1985
- Pharm.D., University of Minnesota - (Minneapolis, Minnesota, United States) 1985
- University of Illinois at Chicago - (Chicago, Illinois, United States) , Postdoctoral Training 2000
awards and honors
- Irma Lerma Rangel College of Pharmacy Preceptor of the Year Award, conferred by Texas A&M University - (College Station, Texas, United States), 2019
- Fellow, conferred by American College of Chest Physicians - (Glenview, Illinois, United States), 2013
- Fellow, conferred by American College of Clinical Pharmacology, 1996
Contact
first name
- George
has last name
- Udeani
Other
In the News
- udeani@tamu.edu